(n) :
(pharmacology) A nonsteroidal aromatase inhibitor C₁₇H₁₁N₅ (trademark Femara) that is administered orally to treat breast cancer in postmenopausal women.
(n) :
(pharmacology) A nonsteroidal aromatase inhibitor C₁₇H₁₁N₅ (trademark Femara) that is administered orally to treat breast cancer in postmenopausal women.